Vaxil Bio Ltd. (TSXV:VXL)
Canada · Delayed Price · Currency is CAD 0.1100
0.00 (0.00%)
Nov 6, 2026, 10:12 AM EST
Vaxil Bio Market Cap
Vaxil Bio has a market cap or net worth of CAD 438.24 thousand as of November 9, 2026. It is the 50,760th most valuable company in the world and the 2,650th biggest in Canada. Its market cap has decreased by 5.90% in one year.
Market Cap
438.24K
Enterprise Value
-25.76K
Revenue
n/a
Global Rank
Country Rank
#2,650 Canada
PE Ratio
1.00
ChartMarket Cap Chart
Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 438.24K, an increase of 350.14%. That is a compound annual growth rate of 15.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 438.24K | -24.14% |
| Dec 30, 2025 | 577.68K | -83.13% |
| Dec 29, 2023 | 3.42M | 25.00% |
| Dec 30, 2022 | 2.74M | -73.33% |
| Dec 31, 2021 | 10.27M | -70.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quest PharmaTech | 4.23M |
| Innovotech | 3.27M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 1.59M |
| Universal Ibogaine | 1.56M |
| Waverley Pharma | 1.08M |
| Doseology Sciences | 801.16K |
| MindBio Therapeutics | 655.48K |